 explains its decision-making, and if necessary, gets more studies. Because I think we can all agree that women's safety here is paramount. And that's exactly what plaintiffs are focused on. That's exactly what the FDA should be focused on. And so let's just do that. Let's focus on the women's safety and ensure that the studies that we're looking at actually apply to the situation at hand.